SPECIALTY TOBACCO COUNCIL, INC.

Lobbying for SPECIALTY TOBACCO COUNCIL INC

Amended

The filer submitted a later report covering this same period, so the amounts here have been replaced. Site totals count only the latest version. See the current filing, posted Jun 3, 2025.

Filing 1st Quarter - Report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Jun 3, 2025

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

North Carolina

Official filing document

Government bodies contacted 4

Food & Drug Administration (FDA)
Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 2

Tobacco

FDA regulation of tobacco products, PL 111-31. To ensure fair and reasonable regulation of industry

Trade (domestic/foreign)

To ensure FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissible restrictions on trade, PL 111-31.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.